Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study

Author:

Eurich D. T.12,Weir D. L.34,Simpson S. H.5,Senthilselvan A.1,McAlister F. A.6

Affiliation:

1. School of Public Health; University of Alberta; Edmonton Alberta Canada

2. ACHORD, 2-040 Li Ka Shing Center; University of Alberta; Edmonton Alberta Canada

3. Department of Epidemiology and Biostatistics; McGill University; Montreal Quebec Canada

4. Clinical and Health Informatics Research Group; Department of Epidemiology and Biostatistics; McGill University; Montreal Quebec Canada

5. Faculty of Pharmacy and Pharmaceutical Sciences; University of Alberta; Edmonton Alberta Canada

6. Department of Medicine; Faculty of Medicine and Dentistry; University of Alberta; Edmonton Alberta Canada

Funder

Canadian Diabetes Association

Canadian Institutes of Health Research

Alberta Innovates Health Solutions (AIHS)

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference37 articles.

1. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group;Amato;Diabetes Metab,1997

2. Approach to the management of diabetic patients with heart failure: role of thiazolidinediones;Fonarow;Am Heart J,2004

3. Spectrum of heart failure in older patients: results from the National Heart Failure project;Havranek;Am Heart J,2002

4. Heart failure: the frequent, forgotten, and often fatal complication of diabetes;Bell;Diabetes Care,2003

5. Alogliptin after acute coronary syndrome in patients with type 2 diabetes;White;NEJM,2013

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Sitagliptin: the world’s first DPP-4 inhibitor;Medical Council;2019-08-21

2. Treatment of Diabetes in Patients with Heart Failure;Current Cardiology Reports;2018-08-27

3. Acute vs cumulative benefits of metformin use in patients with type 2 diabetes and heart failure;Diabetes, Obesity and Metabolism;2018-07-30

4. IMPACT OF DRUG EXPOSURE DEFINITIONS ON OBSERVED ASSOCIATIONS IN PHARMACOEPIDEMIOLOGY RESEARCH;Journal of Population Therapeutics and Clinical Pharmacology;2018-03-20

5. The safety of gliptins : updated data in 2018;Expert Opinion on Drug Safety;2018-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3